These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9280880)

  • 41. [Cefaclor therapy followed by serum sickness-like symptoms].
    Szalai Z; Asbóth D; Török E
    Orv Hetil; 1997 Apr; 138(14):855-8. PubMed ID: 9162894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chronic infection caused by Epstein-Barr virus and chronic fatigue syndrome].
    Med Clin (Barc); 1990 Mar; 94(8):315-6. PubMed ID: 2342394
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction.
    Hall G; Heimdahl A; Nord CE
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):646-9. PubMed ID: 8894572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cefaclor revisited.
    Meyers BR
    Clin Ther; 2000 Feb; 22(2):154-66. PubMed ID: 10743978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum sickness in a paediatric emergency department: the role of cefaclor.
    Parshuram CS; Phillips RJ; Nash MC
    J Paediatr Child Health; 1999 Apr; 35(2):223-4. PubMed ID: 10365368
    [No Abstract]   [Full Text] [Related]  

  • 46. A case of drug eruption due to simultaneous sensitization with three different kinds of drugs.
    Nagayama H; Nakamura Y; Shinkai H
    J Dermatol; 1996 Dec; 23(12):899-901. PubMed ID: 9037924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma.
    Tokura Y; Ishihara S; Tagawa S; Seo N; Ohshima K; Takigawa M
    J Am Acad Dermatol; 2001 Oct; 45(4):569-78. PubMed ID: 11568749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis.
    Asada H
    J Dermatol Sci; 2007 Mar; 45(3):153-60. PubMed ID: 17169531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cephalosporin allergy.
    Madaan A; Li JT
    Immunol Allergy Clin North Am; 2004 Aug; 24(3):463-76, vi-vii. PubMed ID: 15242721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cephalosporins can be prescribed safely for penicillin-allergic patients.
    Pichichero ME
    J Fam Pract; 2006 Feb; 55(2):106-12. PubMed ID: 16451776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic profile of cefaclor.
    Sourgens H; Derendorf H; Schifferer H
    Int J Clin Pharmacol Ther; 1997 Sep; 35(9):374-80. PubMed ID: 9314090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cefaclor allergy and Epstein-Barr virus infection].
    József I
    Orv Hetil; 1997 Jul; 138(28):1833-4. PubMed ID: 9280880
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.